|

IDB-011 dose level 3 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • IDBiologics, Inc.1

Indications

  • Liver Disease1
  • Rift Valley Fever1

Cypress, California1 trial

Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011

Altasciences Clinical Los Angeles

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.